Early improvements in health-related quality of life for epilepsy patients were sustained over several years of treatment with the antiepileptic drug levetiracetam, according to new research presented today by Yale School of Medicine researchers at the...
Yale neurovirology expert Anthony van den Pol and colleagues have received a $2 million grant from the National Institutes of Health to study Cytomegalovirus (CMV), a virus which can lead to deafness, mental retardation and brain diseases such as...